A multicenter, randomized, parallel-group, placebo-controlled, efficacy and safety trial to evaluate the effect of SCH 497079 on weight in obese and overweight subjects.

Trial Profile

A multicenter, randomized, parallel-group, placebo-controlled, efficacy and safety trial to evaluate the effect of SCH 497079 on weight in obese and overweight subjects.

Completed
Phase of Trial: Phase II

Latest Information Update: 02 Nov 2016

At a glance

  • Drugs SCH 497079 (Primary)
  • Indications Obesity
  • Focus Therapeutic Use
  • Sponsors Merck Sharp & Dohme
  • Most Recent Events

    • 15 May 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 30 Oct 2008 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 25 Jul 2008 The expected completion date for this trial is now 1 Jan 2009 (information from ClinicalTrials.gov)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top